This week, we are highlighting this 2019 post by Jenna Finley, one of our current Biology & Life Sciences subject editors. The post was selected by her co-editor, Qiaochu Liang, who observed that the post “serves as a reminder of the historical context of MS treatments and underscores the importance of acknowledging the research efforts that have paved the way for advancements in understanding and managing this condition”. She notes that, although the post is from 4 years ago, it’s perhaps more relevant now than ever, as an MS research network is currently being established in British Columbia. The initiative is possible thanks to an anonymous donation of $33.8 million in 2022, and aims to pioneer next-generation therapeutics for MS patients.
By Jenna Finley, Biology & Life Science co-editor
Multiple sclerosis (MS) is a disease most people have heard of, but may not know much about. It’s classified as an autoimmune disease, which affects the central nervous system (CNS) – the brain and the spinal cord. It is the result of the immune cells in your body […]
